CORONAVIRUS STATUS. MAY 1, 2021

 

The Impact of the COVID-19 Pandemic on Vascular Surgery Trainees in the United States

The Impact of the COVID-19 Pandemic on Vascular Surgery Trainees in the United States

Ann Vasc Surg 2021; 72: 182–190 https://doi.org/10.1016/j.avsg.2020.09.045
2020 Elsevier Inc. All rights reserved. Manuscript received: August 20, 2020; manuscript accepted: September 16, 2020; published online: 3 November 2020

NATURAL HISTORY OF PERIPHERAL ARTERY DISEASE

ATLAS OF VASCULAR DISEASE

Mark Creager

 

TREATMENTS TARGETS AND GOALS FOR CARDIOVASCULAR DISEASE PREVENTION

 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

THE IWGDF 2019 RISK STRATIFICATION SYSTEM

 IWGDF GUIDELINES 2019

CORONAVIRUS STATUS, APRIL 1, 2021

 

JORNADAS DE ACTUALIZACIÓN EN INSUFICIENCIA VENOSA CRÓNICA

Miércoles 10 de marzo de 2021 a las 20h00

Miércoles 17 de marzo de 2021 a las 20h00

Miércoles 24 de marzo de 2021 a las 20h00

 

CORONAVIRUS STATUS. MARCH 3, 2021

 

CRITICAL ISSUES AMERICA. APRIL 16 - 17, 2021. MIAMI, FLORIDA

 

THE THREE PHASES OF THE COAGULATION CASCADE AND TARGETS FOR ANTICOAGULANTS

 

European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

CORONAVIRUS STATUS. FEBRUARY 1, 2021

 

(ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Monitoring and surveillance after deep vein thrombosis

 

CORONAVIRUS STATUS. DECEMBER 28, 2020

 

Direct oral anticoagulants in patients with chronic kidney disease

 

International Journal of Nephrology and Renovascular Disease 

 Open Access Full Text Article http://dx.doi.org/10.2147/IJNRD.S105771 

Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations

CORONAVIRUS STATUS. OCTOBER 19, 2020